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The 7th annual conference of the British Psychosocial Oncology Group was held in York in December 1990. The papers presented at the meeting covered two main themes: quality of life and communication. Fifteen posters were presented covering a variety of topics which included the psychosocial morbidity associated with treatment for cancer, coping skills, interviewing skills and the care of the terminally ill. The debate between Professors Michael Baum and Karol Sikora addressed the issue 'Can we learn Anything of Value from the British Cancer Help Centre?', a timely topic given the recently published report (Bagenal et al., 1990 ).
Quality of life
Three leading exponents in the field of quality of life research, Dr. Neil Aaronson (Netherlands Cancer Institutes), Dr Penelope Hopwood (CRC Psychological Medicine Group, Manchester) and Professor Jimmie Holland (Memorial Sloan Kettering Cancer Centre) gave excellent and timely presentations of their work at the conference.
Dr Aaronson presented data collected from his groups' initial field study of the EORTC questionnaire on patients with lung cancer from 17 different countries. Five hundred and thirty-seven patients with irresectable lung cancer with a minimum prognosis of 3 months completed questionnaires at two time points -a baseline assessment (prior to the start of treatment), and after their first course of treatment. Complete data sets were collected from 430 patients. The reasons for non-completion were mainly due to advanced disease, although administrative failure accounted for some 30% of non-completion. However the overall response rate of 80% was sufficient to allow further analyses of the psychometric properties of the instrument. The importance of item scaling, analysis of covariance of sub-scales, factor analysis and validation with external criteria such as symptomatology etc. was demonstrated clearly in Dr Aaronson's talk. As a result of this fieldwork the group have been able to recognise inappropriate wording of questions which altered reliability and they have also been able to shorten the questionnaire from 36 to 30 items. It now takes less than 14 min to complete and few patients require help with the questionnaire. Finally, the need of having good baseline data with which to compare responsiveness to change was emphasised. Professor Baum suggested four reasons why patients appear to vote with their feet and attend the Bristol Centre. First, unrealistic expectations, second to get away from 'bad doctors', third patients with a personality trait who want to maintain a locus of control and finally, confusion, where patients feel the need for spiritual support but cannot find this in their society. The way out of this morass is through science and working with the Bristol Centre and investigating their claims of enhancing quality of life. He warned of the danger of faith masquerading as science because this results in the uncontrolled fungating cancer on the chest wall which has been treated by wishful thinking.
Responding in favour of alternative therapy and the Bristol Centre, Professor Sikora looked at four situations: early breast cancer, early prostate cancer, inoperable lung cancer and metastatic colorectal cancer. There are many different ways that science has resulted in dealing with these diseases: for example, the type of operation given for breast cancer varies from consultant to consultant; and men with early prostate cancer seeing a urologist will be given a prostatectomy, whereas men seeing a radiotherapist will be given radiotherapy.
The Bristol Centre is about bringing the two side of orthodox and alternative (or complementary) therapy together; extremists are not helpful to patients as patients need a balanced point of view. Professor Sikora believed that the Bristol Centre has given us that balance.
Surveys by Professor Sikora and Dr Slevin have shown that many patients are already using alternative therapies. Professor Sikora has found that of patients attending the Hammersmith Hospital, London, 10% were using some form of complementary therapy for cancer and 33% were using complementary therapy for other conditions, such as arthritis.
Professor Sikora summarised the values of the Bristol Centre as:
(i) identifying unrecognised needs in cancer patients; (ii) indicating that patients want to help themselves and it is our responsibility to focus their activity; (iii) the Bristol Centre has shown us not to use the rigid medical model. The discussion which followed covered the publishing of the evaluation of the Bristol Centre, whether a randomised design would have been possible for the evaluation of individual therapies such as the Bristol diet, the importance of considering the needs of individual people who have cancer and whether the Bristol Centre has contributed anything above the work carried out for many years in the United States of America.
In his closing remarks Professor Baum reminded the audience of the success of the medical model in the last 100 years in surgery, conquering infectious disease, diabetes, tuberculosis, renal disease etc. Professor Baum believes that alternative treatments for cancer will become less popular once we find a way for improving the medical model.
In his closing remarks, Professor Sikora stated that he disagreed with Professor Baum's views about the Bristol Centre and concluded that we need to look at the Bristol Centre and find out which parts of it are important and why some patients find it helpful and others do not, and then bring these back into orthodox medicine. This is what his project at the Hammersmith Hospital aims to do, and the cost of their project to date has been minuscule compared to the cost of a cancer centre.
Communication and intervention
There were three papers in this final session, two of which addressed the issue of communication skills in cancer care, and the third described the psychotherapy trial currently being undertaken at the Royal Marsden Hospital.
Mrs Susie Wilkinson (Stockport Health Authority) reported a study investigating the extent to which ward nurses had difficulty in communicating with patients when taking a nursing history on hospital admission. She sought to clarify whether the nurses lacked communication skills or had skills which they were not using. The aim of the study was to identify those factors predictive of a communication style which facilitated discussion of patient's problems with coverage of emotional as well as physicial topics. Six Dr Watson presented an update on the progress of the trial of Adjuvant Psychological Therapy conducted at the Royal Marsden Hospital. A consecutive series of 1200 patients has now been screened for psychological distress and the 23% of the sample who scored high for psychological morbidity were invited to take part in the adjuvant psychotherapy trial. The aim of this intervention is to maximise patients' involvement in rewarding aspects of life unrelated to cancer and to enable more constructive use of the time spent focusing on the disease, for example in appropriate expression of emotion.
Dr Watson proposed a model of the cycle by which psychological morbidity may develop. The person with a type C personality and a fatalistic attitude, is hypothesised to respond to a diagnosis of cancer by blocking emotional expression, controlling anger and anxiety and thereby experiencing feelings of hopelessness and helplessness. These are then associated with increased psychological morbidity i.e. higher levels of anxiety and depression. The discussion following this paper pursued the issue of whether these psychological responses could be changed, and how change could occur through psychotherapy. Dr Watson pointed out the tentative nature of the model and emphasised the need for continuing research.
The conference was closed by the Chairman of the BPOG, Dr Maurice Slevin.
The eighth annual conference will be held in London on December 9-10 1991. 
